SCHEMBL27987404

SCHEMBL27987404

Cc1ccc(Nc2cncc(NC3CCNC3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 1/20 0.43
▸ TYRO3 Q06418 1/20 0.43
▸ MERTK Q12866 1/20 0.43
▸ KCNH2 Q12809 3/20 0.43
▸ SCN5A Q14524 1/20 0.43
▸ SCN9A Q15858 1/20 0.43
▸ CLK2 P49760 1/20 0.41
▸ CLK3 P49761 1/20 0.41
▸ DYRK1A Q13627 1/20 0.41
▸ ITK Q08881 1/20 0.41
▸ MAP4K1 Q92918 1/20 0.40
▸ BRD4 O60885 4/20 0.40
▸ ATAD2 Q6PL18 4/20 0.40
▸ SYK P43405 2/20 0.39
▸ MAPK3 P27361 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ AURKB Q96GD4 1/20 0.39
▸ HAO1 Q9UJM8 1/20 0.38
▸ PLK4 O00444 2/20 0.38
▸ PAK4 O96013 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27987403 1.00 AXL (0.43) AXLTYRO3MERTKKCNH2SCN5A
SCHEMBL28814769 0.81 PRKCI (0.47) MAP4K1IRAK4
SCHEMBL28814767 0.81 PRKCI (0.47) MAP4K1IRAK4
SCHEMBL27987771 0.80 PRKCI (0.47) CLK2CLK3DYRK1AMAP4K1BRD4
SCHEMBL13354595 0.79 HRH3 (0.42) CLK2CLK3DYRK1AMAP4K1BRD4
SCHEMBL15219256 0.79 CLK2 (0.44) CLK2CLK3DYRK1AMAP4K1BRD4
SCHEMBL4131760 0.77 ITK (0.50) AXLTYRO3MERTKKCNH2ITK
SCHEMBL11916057 0.76 HRH4 (0.45) CLK2CLK3DYRK1AMAP4K1BRD4
SCHEMBL14955891 0.76 SYK (0.52) AXLTYRO3MERTKKCNH2CLK2
SCHEMBL14955888 0.76 SYK (0.52) AXLTYRO3MERTKKCNH2CLK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104066431-B Pyrazine kinase inhibitors 波托拉医药品公司 2017-03-08 — — CN disclosed
CN-104066431-A Pyrazine kinase inhibitors PORTOLA PHARM INC 2014-09-24 — — CN disclosed
Send feedback